Search clinical trials for: Growth hormone
Total 28741 results
-
University of Michigan Rogel Cancer CenterCompletedMultiple MyelomaUnited States, Canada
-
Bristol-Myers SquibbExelixisCompletedAdvanced Cancer, Various, NOSUnited States
-
Chiba UniversityCompleted
-
PfizerTerminatedProstatic NeoplasmsUnited States, Canada, Spain, Belgium, Finland, Italy, Korea, Republic of, Poland, Portugal, Slovakia, Sweden, Denmark, Taiwan, China, Australia, Germany, Israel, United Kingdom, Brazil, France, Czech Republic, Peru
-
Stichting European Myeloma NetworkJanssen PharmaceuticaRecruitingMultiple MyelomaAustria, Greece, Italy, Netherlands, Germany
-
Stichting Hemato-Oncologie voor Volwassenen NederlandNot yet recruiting
-
Massachusetts General HospitalSanofi; GlaxoSmithKlineNot yet recruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapsed CancerUnited States
-
The First Affiliated Hospital with Nanjing Medical...Recruiting
-
Washington University School of MedicineKaryopharm Therapeutics IncRecruitingMultiple Myeloma | Myeloma-Associated AmyloidosisUnited States
-
University of ChicagoGlaxoSmithKline; AmgenRecruitingMultiple Myeloma | Relapse Multiple MyelomaUnited States
-
Regeneron PharmaceuticalsRecruitingRelapsed Refractory Multiple Myeloma (RRMM)Canada, United States, Korea, Republic of, Israel, Taiwan, Spain, Australia, Brazil, France, United Kingdom, Poland, Singapore, Netherlands, Italy
-
Hellenic Society of HematologyGlaxoSmithKlineNot yet recruitingNeoplasms | Multiple Myeloma | Neoplasms, Plasma Cell | Paraproteinemias | Blood Protein Disorders | Corneal Disease | Multiple Myeloma in Relapse | Gammopathy, Monoclonal | Haematologic Disease
-
Janssen Research & Development, LLCRecruitingMultiple MyelomaKorea, Republic of, Russian Federation, Spain, Germany, Belgium, Denmark, Greece, France, United States, Ukraine, Poland
-
European Myeloma NetworkKaryopharm Therapeutics IncRecruitingMultiple MyelomaSpain, United States, Germany, Netherlands, Greece, France, Italy
-
University of Colorado, DenverNational Cancer Institute (NCI); Karyopharm Therapeutics IncRecruitingMultiple Myeloma in RelapseUnited States
-
GlaxoSmithKlineRecruitingMultiple MyelomaChina, Korea, Republic of, Australia, Italy, Spain, United States, Brazil, Czechia, France, Germany, Greece, Israel, Japan, New Zealand, Poland, Russian Federation, Turkey, United Kingdom
-
Memorial Sloan Kettering Cancer CenterJanssen PharmaceuticalsActive, not recruiting
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Canada, Japan, Puerto Rico
-
University of Heidelberg Medical CenterActive, not recruiting
-
CelgeneTerminatedMultiple MyelomaUnited States, Canada, Spain, Italy, Denmark, United Kingdom, Belgium, Sweden, Germany
-
Attaya SuvannasankhaJanssen Scientific Affairs, LLC; Indiana Institute for Medical ResearchWithdrawnMultiple MyelomaUnited States
-
Tel-Aviv Sourasky Medical CenterCompletedPlasma Cell Myeloma | Myeloma-Multiple | Myeloma Multiple | Myeloma, Plasma-CellIsrael
-
SanofiCompletedPlasma Cell MyelomaUnited States
-
National Cancer Institute (NCI)Celgene; Onyx Therapeutics, Inc.CompletedMultiple MyelomaUnited States
-
Lundquist Institute for Biomedical Innovation at...Allergan; Doheny Image Reading CenterWithdrawnDiabetic Macular Edema | Cataract
-
Vejle HospitalCompleted
-
Vitreous -Retina- Macula Consultants of New YorkQLT Inc.WithdrawnAge Related Macular Degeneration
-
Raj K. Maturi, MDAllerganCompletedDiabetic Macular EdemaUnited States
-
Maturi, Raj K., M.D., P.C.CompletedDiabetic Macular EdemaUnited States
-
AllerganTerminatedAge-Related Maculopathy | Subfoveal Choroidal NeovascularizationUnited States
-
RenJi HospitalThe First Affiliated Hospital with Nanjing Medical University; The First Affiliated... and other collaboratorsRecruiting
-
Peking Union Medical College HospitalRecruitingSolitary PlasmacytomaChina
-
Genentech, Inc.Hoffmann-La RocheRecruitingMultiple MyelomaKorea, Republic of, United States, Denmark, Italy, Spain, France, Japan, Israel, United Kingdom, Poland, Australia, Canada, Czechia
-
Canadian Myeloma Research GroupGlaxoSmithKlineRecruitingRelapsed and/or Refractory Multiple MyelomaCanada
-
SanofiCompletedPlasma Cell MyelomaFrance, Spain, Greece, Korea, Republic of, United States, Australia, Belgium, Canada, Czechia, Denmark, Germany, Hungary, Italy, Japan, New Zealand, Norway, Poland, Portugal, Russian Federation, Slovakia, Sweden, Taiwan, Turkey, United...
-
GlaxoSmithKlineActive, not recruiting
-
Massachusetts General HospitalSanofi; AmgenActive, not recruiting
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; Celgene; The Leukemia and Lymphoma Society; Multiple Myeloma... and other collaboratorsCompletedSmoldering Multiple Myeloma | Smoldering MyelomaUnited States
-
University of ChicagoActive, not recruitingMultiple MyelomaUnited States, Poland
-
Bristol-Myers SquibbAbbVieCompleted
-
University of Heidelberg Medical CenterCompleted
-
Merck Sharp & Dohme LLCTerminated
-
AllerganCompletedMacular Edema | Retinal Vein OcclusionFrance, United Kingdom, Spain, Israel, Germany, Italy
-
Institut de Cancérologie de la LoireCelgene CorporationCompletedLeukemia, Lymphoid | Precursor B-Cell Lymphoblastic Leukemia-LymphomaFrance
-
University of LeipzigMundipharma Pte Ltd.; Celgene Corporation; AmgenUnknown
-
Federal University of São PauloNovartisWithdrawnChoroidal Neovascularization | Retinal Pigment Epithelial DetachmentBrazil
-
Eli Lilly and CompanyCompleted
-
John SledgeNot yet recruitingOsteoarthritis, KneeUnited States
-
Merck KGaA, Darmstadt, GermanyCompletedAdult Growth Hormone DeficiencyUnited Kingdom, Germany, Australia, Sweden
-
GeneScience Pharmaceuticals Co., Ltd.First Affiliated Hospital, Sun Yat-Sen University; Huazhong University of Science... and other collaboratorsCompletedEfficiency and Safety Study of Pegylated Somatropin to Treat Growth Hormone Deficiency Children (PD)Growth Hormone Deficiency